ChAd63/MVA Pfs25-IMX313

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameChAd63/MVA Pfs25-IMX313

Drug Alias NameChAd63 Pfs25-IMX313 and MVA Pfs25-IMX313 prime-boost vaccine (University of Oxford/Jenner Institute)malaria transmission-blocking vaccine(Jenner Institute/University of Oxford/Osivax)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsMalaria

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsYes

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Oxford

China Registration ClassN/A

Develop Information

Active CompaniesThe Jenner Institute University Of Oxford

Inactive CompaniesN/A

Active IndicationsMalaria

Inactive IndicationsN/A

Other Information

ATC CodeN/A